EQT Client Assets Rise While Investments, Fund Exits Slip
By Elena Vardon
EQT reported a rise in assets under management in the first quarter, while the investments by its funds and fund exits were lower than the previous year.
The Swedish private-equity company said Thursday that its fee-generating assets under management rose to 132 billion euros ($140.89 billion) at the end of March from EUR119 billion a year prior. Total assets under management stood at EUR242 billion, up from EUR216 billion, it said.
"Fundraisings are generally taking longer in the current fundraising environment, and we expect the fundraising market to meaningfully improve only once realizations pick up materially across private markets," the group said.
Investments by its funds reached EUR4 billion, compared with EUR5 billion the previous year, the group said. Total gross fund exits in the three month period amounted to EUR1 billion, against EUR2 billion.
"Investment activity continued at a good pace and, with transactions such as the IPO of Galderma, we expect a gradual increase in exit activity," Chief Executive Christian Sinding said.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
April 18, 2024 02:07 ET (06:07 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?